Stealth BioTherapeutics

Investor Presentation – October 2022

Maxim Group 2022 Virtual Growth Conference

KOL Discussion on the Potential of Elamipretide in Treatment of Geographic Atrophy in AMD

February Presentation – February 2022

Third Quarter 2021 Financial Results Earnings Call

Second Quarter 2021 Financial Results Earnings Call

Stealth Q2 2021 Webcast

Jefferies Healthcare Conference

Stealth Q1 2021 Webcast

First Quarter 2021 Financial Results Earnings Call

Q4 2020 Earnings Webcast

Oppenheimer’s 31st Annual Healthcare Conference at 10:40 am ET

H.C. Wainwright Virtual BioConnect Conference

Conference Call

Stealth BioTherapeutics Third Quarter 2020 Earnings Call

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Cantor Fitzgerald’s Virtual Global Healthcare Conference 2020

H.C. Wainwright 22nd Annual Global Investment Conference

Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results

Stealth BioTherapeutics Fireside Chat: BMO 2020 Prescriptions for Success Healthcare Virtual Conference

Jefferies 2020 Healthcare Conference

UBS Virtual Global Healthcare Conference

Q1 2020 Earnings Conference Call

Q4 2019 Earnings Call and Webcast

Stealth BioTherapeutics Presentation at 40th Annual Cowen Health Care Conference

Barth Syndrome Efficacy Study Using Natural History Data as a Control

Barth Syndrome Efficacy Study Using Natural History Data as a Control

Stealth BioTherapeutics Inc. Conference Call Webcast

Jefferies London Healthcare Conference

Stealth Announces Co-Development Partnership with Alexion for Mitochondrial Disease